Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill Barber

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Journal of Pharmaceutical Sciences|July 25, 2022
Quantitative Assessment of the Impact of Crohn's Disease on Protein Abundance of Human Intestinal Drug-Metabolising Enzymes and TransportersSarah Alrubia, Zubida M Al-Majdoub, Brahim Achour, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 19, 2026
Overlooked aspects of scaling enzyme activity through abundance across tissues and individuals: Insights from k<sub>cat</sub> measurements in matched liver and intestinal samplesZubida M Al-Majdoub, Jill Barber, Amin Rostami-Hodjegan, et al.
British Journal of Clinical Pharmacology|March 5, 2025
Variability in intestinal drug metabolizing enzymes and transporters in Crohn's disease and potential impact on oral drug absorptionSarah Alrubia, Brahim Achour, Zubida M Al-Majdoub, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 28, 2021
Proteomic Quantification of Changes in Abundance of Drug-Metabolizing Enzymes and Drug Transporters in Human Liver Cirrhosis: Different Methods, Similar OutcomesEman El-Khateeb, Zubida M Al-Majdoub, Amin Rostami-Hodjegan, et al.
Molecular Pharmaceutics|August 24, 2021
Non-uniformity of Changes in Drug-Metabolizing Enzymes and Transporters in Liver Cirrhosis: Implications for Drug Dosage AdjustmentEman El-Khateeb, Brahim Achour, Zubida M Al-Majdoub, et al.
Materials (Basel, Switzerland)|November 27, 2021
Selected Derivatives of Erythromycin B-<i>In Silico</i> and Anti-Malarial StudiesPranab K Bhadra, Rachael N Magwaza, Niroshini Nirmalan, et al.
Clinical Pharmacology and Therapeutics|March 4, 2026
Unveiling Hepatic Protein Alterations in Neonatal and Infant Biliary AtresiaZubida M Al-Majdoub, Martyn Howard, Brahim Achour, et al.
Organic & Biomolecular Chemistry|June 9, 2016
Enhancement of the properties of a drug by mono-deuteriation: reduction of acid-catalysed formation of a gut-motilide enol ether from 8-deuterio-erythromycin BPranab K Bhadra, Abdolreza Hassanzadeh, Biljana Arsic, et al.
Clinical Pharmacology and Therapeutics|August 14, 2021
Quantitative Proteomic Map of Enzymes and Transporters in the Human Kidney: Stepping Closer to Mechanistic Kidney Models to Define Local KineticsZubida M Al-Majdoub, Daniel Scotcher, Brahim Achour, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 1, 2020
Proteomic characterisation of drug metabolising enzymes and drug transporters in pig liverYasmine Elmorsi, Hajar Al Feteisi, Zubida M Al-Majdoub, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Journal of Pharmaceutical Sciences|July 25, 2022
Quantitative Assessment of the Impact of Crohn's Disease on Protein Abundance of Human Intestinal Drug-Metabolising Enzymes and TransportersSarah Alrubia, Zubida M Al-Majdoub, Brahim Achour, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 19, 2026
Overlooked aspects of scaling enzyme activity through abundance across tissues and individuals: Insights from k<sub>cat</sub> measurements in matched liver and intestinal samplesZubida M Al-Majdoub, Jill Barber, Amin Rostami-Hodjegan, et al.
British Journal of Clinical Pharmacology|March 5, 2025
Variability in intestinal drug metabolizing enzymes and transporters in Crohn's disease and potential impact on oral drug absorptionSarah Alrubia, Brahim Achour, Zubida M Al-Majdoub, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 28, 2021
Proteomic Quantification of Changes in Abundance of Drug-Metabolizing Enzymes and Drug Transporters in Human Liver Cirrhosis: Different Methods, Similar OutcomesEman El-Khateeb, Zubida M Al-Majdoub, Amin Rostami-Hodjegan, et al.
Molecular Pharmaceutics|August 24, 2021
Non-uniformity of Changes in Drug-Metabolizing Enzymes and Transporters in Liver Cirrhosis: Implications for Drug Dosage AdjustmentEman El-Khateeb, Brahim Achour, Zubida M Al-Majdoub, et al.
Materials (Basel, Switzerland)|November 27, 2021
Selected Derivatives of Erythromycin B-<i>In Silico</i> and Anti-Malarial StudiesPranab K Bhadra, Rachael N Magwaza, Niroshini Nirmalan, et al.
Clinical Pharmacology and Therapeutics|March 4, 2026
Unveiling Hepatic Protein Alterations in Neonatal and Infant Biliary AtresiaZubida M Al-Majdoub, Martyn Howard, Brahim Achour, et al.
Organic & Biomolecular Chemistry|June 9, 2016
Enhancement of the properties of a drug by mono-deuteriation: reduction of acid-catalysed formation of a gut-motilide enol ether from 8-deuterio-erythromycin BPranab K Bhadra, Abdolreza Hassanzadeh, Biljana Arsic, et al.
Clinical Pharmacology and Therapeutics|August 14, 2021
Quantitative Proteomic Map of Enzymes and Transporters in the Human Kidney: Stepping Closer to Mechanistic Kidney Models to Define Local KineticsZubida M Al-Majdoub, Daniel Scotcher, Brahim Achour, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 1, 2020
Proteomic characterisation of drug metabolising enzymes and drug transporters in pig liverYasmine Elmorsi, Hajar Al Feteisi, Zubida M Al-Majdoub, et al.
Pageof 8